Study: NCT05582499

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dalpiciclib
Description: an oral cyclin-dependent kinases (CDK) 4/6 inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyrotinib
Description: an irreversible dual pan-erbb receptor tyrosine kinase receptor tyrosine kinase (ERBB) inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyrotinib
Description: an irreversible dual pan-erbb receptor tyrosine kinase receptor tyrosine kinase (ERBB) inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyrotinib
Description: an irreversible dual pan-erbb receptor tyrosine kinase receptor tyrosine kinase (ERBB) inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyrotinib
Description: an irreversible dual pan-erbb receptor tyrosine kinase receptor tyrosine kinase (ERBB) inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A1811
Description: an anti-HER2 antibody-drug conjugate (ADC)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A1811
Description: an anti-HER2 antibody-drug conjugate (ADC)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A1811
Description: an anti-HER2 antibody-drug conjugate (ADC)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A1811
Description: an anti-HER2 antibody-drug conjugate (ADC)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A1811
Description: an anti-HER2 antibody-drug conjugate (ADC)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A1811
Description: an anti-HER2 antibody-drug conjugate (ADC)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-1316
Description: an anti-programmed death ligand 1 (PD-L1) antibody

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-1316
Description: an anti-programmed death ligand 1 (PD-L1) antibody

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab
Description: an anti-programmed death-1 (PD1) antibody

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab
Description: an anti-programmed death-1 (PD1) antibody

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A1921
Description: Trophoblast cell-surface antigen 2 (TROP2) ADC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A1921
Description: Trophoblast cell-surface antigen 2 (TROP2) ADC

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pertuzumab
Description: Pertuzumab

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pertuzumab
Description: Pertuzumab

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Trastuzumab
Description: Trastuzumab

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Trastuzumab
Description: Trastuzumab

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Goserelin
Description: goserelin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole
Description: letrozole

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nab paclitaxel
Description: Albumin paclitaxel

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nab paclitaxel
Description: Albumin paclitaxel

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nab paclitaxel
Description: Albumin paclitaxel

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab paclitaxel
Description: Albumin paclitaxel

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nab paclitaxel
Description: Albumin paclitaxel

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab paclitaxel
Description: Albumin paclitaxel

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nab paclitaxel
Description: Albumin paclitaxel

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab paclitaxel
Description: Albumin paclitaxel

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nab paclitaxel
Description: Albumin paclitaxel

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nab paclitaxel
Description: Albumin paclitaxel

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab paclitaxel
Description: Albumin paclitaxel

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nab paclitaxel
Description: Albumin paclitaxel

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab paclitaxel
Description: Albumin paclitaxel

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nab paclitaxel
Description: Albumin paclitaxel

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab paclitaxel
Description: Albumin paclitaxel

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nab paclitaxel
Description: Albumin paclitaxel

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nab paclitaxel
Description: Albumin paclitaxel

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nab paclitaxel
Description: Albumin paclitaxel

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Carboplatin

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Carboplatin

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Carboplatin

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Carboplatin

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Carboplatin

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Carboplatin

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epirubicin
Description: Epirubicin

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epirubicin
Description: Epirubicin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epirubicin
Description: Epirubicin

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epirubicin
Description: Epirubicin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epirubicin
Description: Epirubicin